F
Financials.page
Company Fundamentals
Workspace
OverviewhomeCompaniesdirectoryAPI & MCPdevelopers
Company financial data, refreshed daily. Not investment advice.
Financials.page — company financial data, refreshed daily. Not investment advice. Legal & terms
Annual figures as reported in 10-K / 20-F / 40-F filings.
RLFTY · CIK 0001854078

RELIEF THERAPEUTICS HOLDING SA

Annual figures as reported, FY2020–FY2023. Ratios and growth rates derived on-page.

RLFTY logo
Pharmaceutical Preparations
Company profile
OTC · RLFTYHQ Ch-1202 GenevaIncorporated in V8Fiscal year ends Dec 31Non-accelerated filer Emerging growth companyReports in CHF
Revenue
CHF 6.3M
▼ −11.0% vs FY2022
Net income
−CHF 98.2M
▼ −93.3% vs FY2022
Free cash flow
−CHF 18.1M
▲ +25.3% vs FY2022
Diluted EPS
−CHF 8.35
▼ −73.9% vs FY2022

Revenue

Annual, as reported

02M4M6M’21’22’23CHF 6.3M

Net income

Losses shown in terracotta

−75M−50M−25M0’21’22’23−CHF 98.2M

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

-1500%-1000%-500%0%’21’22’23
Operating marginNet margin

Returns on capital

Net income vs year-end equity and assets

-150%-100%-50%0%’21’22’23
Return on equityReturn on assets

Cash flow

cash generation

Free cash flow

Operating cash flow less capital expenditure

−20M−10M0’22’23−CHF 18.1M

Operating cash flow

Net cash from operations

−30M−20M−10M0’21’22’23−CHF 17.6M

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

01B2B3B’21’22’2312M

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

050M100M150M’20’21’22’23CHF 52.2M

Key ratios

derived per fiscal year
Fiscal yearOp. marginNet marginFCF marginROEROACurrent ratio
FY2023−1751.4%−1551.5%−285.4%−188.0%−128.5%2.65×
FY2022−731.9%−714.3%−339.8%−34.9%−26.9%2.11×
FY2021−763.7%−772.6%—−19.1%−13.8%2.79×
FY2020——————

Annual figures

as reported
Fiscal yearRevenueGross profitOp. incomeNet incomeDiluted EPSOp. cash flowCapexTotal assetsLiabilitiesEquityCashLT debt
FY2023CHF 6.3M—−CHF 110.8M−CHF 98.2M−CHF 8.35−CHF 17.6MCHF 446KCHF 76.4MCHF 24.2MCHF 52.2MCHF 14.6M—
FY2022CHF 7.1M—−CHF 52.0M−CHF 50.8M−CHF 4.80−CHF 24.1MCHF 33KCHF 188.8MCHF 43.4MCHF 145.4MCHF 19.2M—
FY2021CHF 4.5M—−CHF 34.3M−CHF 34.7M−CHF 0.01−CHF 35.7M—CHF 251.6MCHF 70.1MCHF 181.5MCHF 44.8M—
FY2020—————————CHF 67.0MCHF 43.2M—

Latest filings

the most recent regulatory filings
424B3Prospectus2026-04-16 ↗F-6 POSFORM F-6 POST EFFECTIVE AMENDMENT NO. 4 TO REGISTRATION STATEMENT2025-03-27 ↗424B3RULE 424(B)(3) ADR2024-12-17 ↗15F-12GFORM 15-F NOTICE OF TERMINATION2024-12-17 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 20242024-12-16 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 20242024-11-12 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 20242024-11-05 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 20242024-10-28 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 20242024-10-22 ↗6-KFORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 20242024-10-09 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.